Events and Presentations

The IL4 Receptor as a Biomarker and Immunotherapeutic Target for Glioblastoma: Preliminary Evidence with MDNA55, a Locally Administered IL-4 Guided Toxin
Thursday, February 7, 2019
4:05pm EST

John H Sampson, MD, PhD
Robert H. and Gloria Wilkins, Distinguished Professor and Chair of Neurosurgery,
Department of Neurosurgery, Duke University School of Medicine

Click here to view video

 

2 MB
Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
 
Stock Quote
TSXMDNA
Email Alerts
* Required Fields